{
  "name": "Season 1: Episode 1 ",
  "headline": "Immune Checkpoint Inhibitors have been transformative for cancer care. What have we learnt so far?",
  "link_spotify": "https://open.spotify.com/show/11GGvT4Mk6IVelrJpXgY6I",
  "link_apple": "https://podcasts.apple.com/us/podcast/checkpoint-now/id1541046019",
  "hosts": "Dr. Afreen Shariff, MD, Endocrinologist, Duke Division of Endocrinology, Diabetes and Metabolism, Duke Cancer Institute; Dr. Tian Zhang, MD, MHS, Genito-Urinary Oncologist, Duke Cancer Institute"
}